223490-70-8

Basic information

• Product Name: Heptanoic acid, 7-[[(4-butylphenyl)methyl]amino]-, methyl ester
• CAS NO: 223490-70-8
• Molecular Formula: C19H31NO2
• Molecular Weight: 305.461
• Mol File: 223490-70-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Heptanoic acid, 7-[[(4-butylphenyl)methyl]amino]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Heptanoic acid, 7-[[(4-butylphenyl)methyl]amino]-, methyl ester(223490-70-8)
• EPA Substance Registry System: Heptanoic acid, 7-[[(4-butylphenyl)methyl]amino]-, methyl ester(223490-70-8)

Safety Data

• Hazardous Substances Data: 223490-70-8(Hazardous Substances Data)

Upstream product

• 1200-14-2 4-(n-butyl)benzaldehyde 
• 17994-94-4 methyl 7-aminoheptanoate hydrochloride 

Relevant articles and documents

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an EP2 or EP4 selective agonist

The present invention relates to pharmaceutical compositions and methods of treatment comprising administering to a patient in need thereof a combination of a 2-alkylidene-19-nor-vitamin D derivative and an EP2 or EP4 selective agonist or a pharmaceutically acceptable salt or prodrug thereof. Particularly, the present invention relates to pharmaceutical compositions and methods comprising administering to a patient in need thereof 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 and an EP2 or EP4 selective agonist or a pharmaceutically acceptable salt or prodrug thereof.

Prostaglandin agonists and their use to treat bone disorders

This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.